New York, NY·Biotechnology, Healthcare, Pharmaceuticals·Last fund filed 2018
Funds on file
4
Partners named
6
5 on a current fund
Recent board seats
3
last 24 months
Capital raised
$20M
across filed funds
What has New Leaf raised?
4 vehicles
Vehicle
Filed
Target
Sold to date
Investors
New Leaf Biopharma Opportunities II, L.P.Filed to raise in 2018, with no closing reported yet.
2018
$200M
$0
0
New Leaf Ventures IV, L.P.Filed to raise in 2018, with no closing reported yet.
2018
$275M
$0
0
New Leaf Growth Fund I, L.P.
February 2016
$20M
$20M
1
New Leaf Ventures III, L.P.Filed to raise in 2014, with no closing reported yet.
2014
$375M
$0
0
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
Who at New Leaf can lead a round?
6 named
6 partners are named across this firm’s filings, 5 of them on a fund it is deploying now.
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Manufacturing & industrials1 · 3%
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of New Leaf’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
A shared board seat: a company where filings name a New Leaf partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.
